Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Genetic of SportS Induced Endofibrotic Remodeling (GOSSER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02704260
Recruitment Status : Completed
First Posted : March 9, 2016
Last Update Posted : November 1, 2017
Sponsor:
Information provided by (Responsible Party):
University Hospital, Angers

Brief Summary:
search for a genetic cause of vascular endofibrose

Condition or disease Intervention/treatment Phase
Genetic Syndrome Genetic: GENETIC ANALYSIS Not Applicable

Detailed Description:

Perform a DNA analysis to mark the existence of mutations in one or more genes encoding proteins involved in vascular remodeling high.

5 patients or relatives of patients topics


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 5 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Endofibrose Vasculaire et génétique
Actual Study Start Date : March 2, 2016
Actual Primary Completion Date : September 2, 2016
Actual Study Completion Date : September 2, 2016

Arm Intervention/treatment
Experimental: GENETIC ANALISYS
GENETIC ANALYSIS AND RESEARCH OF GENETIC BLOOD SAMPLE
Genetic: GENETIC ANALYSIS
prélevement blood to search for a genetic cause of vascular endofibrose. Search genetic mutations in 5 subjects.




Primary Outcome Measures :
  1. Presence of mutations or nucleotides variations [ Time Frame: 1 hour ]
    DNA analysis and search for genetic mutations



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • High level reached Cyclists vascular endofibrose
  • Cyclist high level and not sick with a brother or sister is senior cyclist reaches the vascular endofibrose.

Exclusion Criteria:

  • not obtaining consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02704260


Locations
Layout table for location information
France
University Hospital
Angers, France, 49933
Sponsors and Collaborators
University Hospital, Angers
Investigators
Layout table for investigator information
Principal Investigator: PIERRE ABRAHAM, PROFESSOR UH ANGERS

Layout table for additonal information
Responsible Party: University Hospital, Angers
ClinicalTrials.gov Identifier: NCT02704260     History of Changes
Other Study ID Numbers: 2015-A00441-48
First Posted: March 9, 2016    Key Record Dates
Last Update Posted: November 1, 2017
Last Verified: December 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided